Kadlubar F, Kaderlik RK, Mulder GJ, Lin D, Butler MA, Teitel CH, et al
5 Mechanisms of OS-mediated pathological changes in the endometrium OS may serve as a pivotal link between obesity and endometrial pathology, and is one of the factors promoting the onset and progression of endometrial diseases
Thnh phn: 250 mg L-glutathione dng Reduced L-glutathione, 100 mg vitamin C dng acid ascorbic v 250 mg L-cysteine dng l-cysteine HCL
Possible side effects include: Injection site pain, redness, or bruising Unwanted facial or body hair growth Copper imbalance, which may cause headaches, nausea, or fatigue Flushing or histamine-type reactions in sensitive individuals Injectable copper peptides may not be appropriate for individuals with liver conditions, disorders of copper metabolism (such as Wilsons disease), or significant inflammatory sensitivity
Their symptoms start around age 40, about 10 years later than in women